In the Margins
Concentrated bets on individual stocks raise issues for mutual funds and their investors—a matter highlighted last week at Sequoia Fund, one of the biggest investors in controversial drug maker Valeant Pharmaceuticals International Inc. Placing outsize bets on well-chosen stocks can lead to strong performance, but concentration increases the riskiness of a fund and raises questions about how much is too much. Read the original story from The Wall Street Journal.
Most Read
Mutual fund boards seem well on their way to mastering the art of conducting business virtually, but one area that may still be a challenge during ...
The world has been turned upside down in the past two months, and it remains unclear if things will ever go back to what we considered ...
Response among mutual fund governance professionals to a proposed rule on fund valuation practices has been generally positive, but industry lawyers anticipate pushback on a number ...
Mutual fund industry lawyers Nathan Greene and Jay Baris today have joined Sidley Austin's LLP's New York office as partners in the Investment Funds group. Both ...